Narrow by location

DOT Changes Drug Testing List

Safety

The U.S. Department of Transportation (DOT) recently issued a final rule that expands the DOT’s current drug testing panel to include some semi-synthetic opioids:

  • Hydrocodon – Trade names Norco, Vicodin, Lortab, Vicoprofen and Riboxen
  • Hydromorphone – Trade name Dilasudid
  • Oxymorphone – Trade name Numorphan
  • Oxycodone – Trade name Eucodal

DOT-regulated employers will be required to test for these highly abused opioids beginning on Jan. 1, 2018.

This change was made to enhance safety, prevent opioid abuse and combat the growing opioid epidemic in the United States. Currently, the DOT requires drug testing of safety-sensitive employees in the transportation industries.

“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”

 

My Safety Complaint Was Unsafe for My Continued Employment

By John W. Hargrove, Bradley OSHA Safety Retaliation – What Is It? Virtually every employee protection law, federal... »

OSHA Increases Civil Penalty Amounts for 2019

From JH Berry Risk Services On Jan. 23, 2019, the Occupational Safety and Health Administration (OSHA) published a final... »

Don’t You (Forget About Me): Can Former Managers’ Statements Bind Companies in OSHA Investigations?

From Fisher Phillips blog An accident happens and an employee is seriously injured and admitted to the hospital. ... »

OSHA Update: Increased Crane Requirements to Ensure Safe Operation

By Carly Miller, Bradley The skylines of most large U.S. cities are scattered with cranes and large-scale equipment... »

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *